Conclusion
Demand assessments are undoubtedly a critical part of any product launch. They give pharmaceutical companies powerful clarity around future uptake and pricing – informing marketing strategy, empowering sales teams and enabling optimised brand performance.
With so much hanging in the balance, accuracy is vital, but achieving it can be challenging. Multiple stakeholders, variable scenarios and layered influences combine to create a complex picture, often obscuring valuable insights and opportunities.
Here at Research Partnership, our response combines a multi-stakeholder approach with linked-choice modelling, assessing not just patients but physicians, payers and the influences they have on each other.
Specifically designed to engage, hold attention and reveal the reality behind stakeholder decisions, it’s an incredibly accurate way to predict real-world behaviour, cut through the noise and deliver the definitive answers – and genuine confidence – every brand needs.